Citadel Advisors’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $496K | Buy |
130,075
+91,412
|
|
||||
|
2025
Q1 | $102K | Buy |
+38,663
|
|
||||
|
2024
Q4 | – | Sell |
-525,964
|
|
||||
|
2024
Q3 | $2.4M | Sell |
525,964
-209,440
|
|
||||
|
2024
Q2 | $3.2M | Buy |
735,404
+158,491
|
|
||||
|
2024
Q1 | $2.9M | Buy |
576,913
+437,417
|
|
||||
|
2023
Q4 | $875K | Buy |
139,496
+134,506
|
|
||||
|
2023
Q3 | $35.5K | Buy |
4,990
+4,937
|
|
||||
|
2023
Q2 | $540 | Sell |
53
-93,069
|
|
||||
|
2023
Q1 | $845K | Sell |
93,122
-55,586
|
|
||||
|
2022
Q4 | $1.07M | Buy |
148,708
+120,772
|
|
||||
|
2022
Q3 | $182K | Sell |
27,936
-19,298
|
|
||||
|
2022
Q2 | $228K | Buy |
47,234
+15,740
|
|
||||
|
2022
Q1 | $179K | Buy |
+31,494
|
|
||||
|
2020
Q3 | – | Sell |
-54,277
|
|
||||
|
2020
Q2 | $399K | Buy |
+54,277
|
|
||||
|
2018
Q3 | – | Sell |
-16,828
|
|
||||
|
2018
Q2 | $95K | Buy |
+16,828
|
|